Mediator complex subunit 9 (MED9)

Mediator complex subunit 9 (MED9) is a protein that forms part of the multiprotein Mediator complex, an essential transcriptional coactivator for nearly all RNA polymerase II-dependent genes[1][3][4]. The Mediator complex serves as a bridge between gene-specific regulatory proteins and the basal RNA polymerase II machinery, facilitating the assembly of the preinitiation complex and proper transcription initiation[1][3][4][5]. MED9 specifically is a structural component contributing to this complex and is necessary for transcription activation by DNA-bound factors[1][2]. Functional studies in cardiac tissue have implicated MED9 in gene regulatory networks important for heart development and maintenance, where altered expression or isoform switching of MED9 is linked to dilated cardiomyopathy, suggesting a potential disease-modifying role[1]. MED9 is not a typical therapeutic target (such as a receptor, enzyme, transporter, or ion channel), and no drugs are known to directly interact with this subunit or modulate its activity in clinical settings. Genetic variants of MED9 may contribute to developmental syndromes such as Smith-Magenis syndrome due to its genomic location[3][4].

Other names

FLJ10193Mediator of RNA polymerase II transcription subunit 9Mediator complex subunit 9Mediator of RNA polymerase II transcription subunit 9 homolog